Pepscan Therapeutics achieves milestones in research collaboration with Janssen R&D Irelad
In the collaboration, Pepscan has discovered novel peptides with potential therapeutic utility using its proprietary peptide array platform for high throughput synthesis and screening of conformationally stabilized CLIPS peptides.
“The achievement of these milestones demonstrates the effectiveness of our high throughput peptide array technology for the discovery of novel peptides with excellent activity and proteolytic stability”, said Wim Mol, CEO of Pepscan. “We consider this achievement a further expression of our expertise in the field of peptide lead discovery and optimization”.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.